Clinical Trial of 26,26,26,27,27,27-Hexafluoro-1,25-Dihydroxyvitamin D3 in Uremic Patients on Hemodialysis: Preliminary Report

2015 ◽  
pp. 196-203 ◽  
Author(s):  
Yoshiki Nishizawa ◽  
Hirotoshi Morii ◽  
Yosuke Ogura ◽  
Hector F. DeLuca
Keyword(s):  
Clinical Trial ◽  
Preliminary Report ◽  
Dihydroxyvitamin D3 ◽  
1,25 Dihydroxyvitamin D3 ◽  
Uremic Patients

Clinical Effects of 1,25-Dihydroxyvitamin D3 in Uremic Patients with Overt Osteodystrophy

2015 ◽  
pp. 29-41 ◽  
Author(s):  
Arnold S. Brickman ◽  
Jack W. Coburn ◽  
Donald J. Sherrard ◽  
Eugene G. C. Wong ◽  
Anthony W. Norman ◽  
...  
Keyword(s):  
Clinical Effects ◽  
Dihydroxyvitamin D3 ◽  
1,25 Dihydroxyvitamin D3 ◽  
Uremic Patients

Multicenter clinical trial of 22-oxa-1,25-dihydroxyvitamin D3 for chronic dialysis patients

2003 ◽  
Vol 41 (3) ◽  
pp. S108-S111 ◽  
Author(s):  
Masako Yasuda ◽  
Takashi Akiba ◽  
Hiroshi Nihei
Keyword(s):  
Clinical Trial ◽  
Chronic Dialysis ◽  
Multicenter Clinical Trial ◽  
Dialysis Patients ◽  
Dihydroxyvitamin D3 ◽  
1,25 Dihydroxyvitamin D3

scholarly journals Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

1993 ◽  
Vol 92 (3) ◽  
pp. 1436-1443 ◽  
Author(s):  
N Fukuda ◽  
H Tanaka ◽  
Y Tominaga ◽  
M Fukagawa ◽  
K Kurokawa ◽  
...  
Keyword(s):  
Severe Form ◽  
Parathyroid Hyperplasia ◽  
D3 Receptor ◽  
Receptor Density ◽  
Dihydroxyvitamin D3 ◽  
1,25 Dihydroxyvitamin D3 ◽  
Uremic Patients

scholarly journals 1,25-Dihydroxyvitamin D3 Restrains CD4+ T Cell Priming Ability of CD11c+ Dendritic Cells by Upregulating Expression of CD31

2019 ◽  
Vol 10 ◽  
Author(s):  
Louise Saul ◽  
Iris Mair ◽  
Alasdair Ivens ◽  
Pamela Brown ◽  
Kay Samuel ◽  
...  
Keyword(s):  
Dendritic Cells ◽  
T Cell ◽  
Cd4 T Cell ◽  
Dihydroxyvitamin D3 ◽  
1,25 Dihydroxyvitamin D3 ◽  
T Cell Priming
Sign in / Sign up

Export Citation Format

Share Document